http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070012060-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02adab046505eb4510516eefc135a09b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2005-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c68ca709e256b3e8e9995c4a9ab2100e |
| publicationDate | 2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20070012060-A |
| titleOfInvention | Percutaneous Patches Containing Paroxetine |
| abstract | The present invention relates to a transdermal patch in the form of a matrix containing paroxetine.n n n The transdermal patch containing paroxetine of the present invention appropriately delays drug transition to systemic blood, thereby reducing the side effects associated with high initial blood levels during oral administration of conventional paroxetine and reducing the widespread metabolism in the liver. useful. In addition, the transdermal patch containing paroxetine of the present invention has a very high skin permeability and shows high bioavailability as compared to oral preparations, and therefore, it is expected that the paroxetine administration method may be replaced by the convenience of application. do. |
| priorityDate | 2005-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.